{"id":953,"date":"2026-09-30T10:49:52","date_gmt":"2026-09-30T05:19:52","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-30\/"},"modified":"2026-10-05T20:40:49","modified_gmt":"2026-10-05T15:10:49","slug":"mankind-share-price-today-2026-09-30","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-30\/","title":{"rendered":"Why Mankind Pharma Shares Fell 1.62% Today: Sector Trends | 30 September 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: MANKIND<\/strong> \u00b7 30 September 2026 \u00b7 Dated market coverage<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b92,503.80<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-1.62%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b92,552.00 \/ \u20b92,455.00<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b92,545.00<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>1,301,940<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>30 Sep 2026 \u2022 03:15 PM IST<\/div>\n<\/div>\n<\/div>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\" class=\"wt-card\">\n<div style=\"font-weight:900;color:#1f4d70;margin-bottom:7px;\" class=\"wt-card-title\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;\">\n<li>The stock is -1.62% at \u20b92,503.80.<\/li>\n<li><strong>Likely reason:<\/strong>Sector-led pullback with elevated trading volume <\/li>\n<li>Approximate traded value is<strong>\u20b9325.98 crore<\/strong>. <\/li>\n<li>It is -5.23% from its 52-week high and +31.11% from its 52-week low.<\/li>\n<li>The stock is being compared with<strong>Nifty Pharma<\/strong>alongside the Nifty 50. <\/li>\n<\/ul><\/div>\n<h2>Why Is Mankind Pharma Share Price Falling 1.62% Today?<\/h2>\n<p class=\"wt-copy\">Latest NSE EOD report: 2026-09-29. Today&#8217;s Volume: 1,301,940; 5-Day Avg. Volume: 891,018; 20-Day Avg. Volume: 521,289; Volume vs 20-Day Avg.: 2.50x; Delivery Quantity: 697,782; Delivery %: 35.35%; Number of Trades: 84,454.<\/p>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Mankind Pharma fell 1.62% during the session, closing at \u20b92503.80 after moving within a day&#8217;s range of \u20b92455.00 and \u20b92552.00. Trading volume was noticeably elevated, recording 1.3 million shares traded, which is 2.5 times the 20-day average volume, pointing to increased market participation during the pullback.<\/p>\n<p class=\"wt-copy\">The broader market and pharmaceutical segment experienced downward pressure, with the Nifty falling 0.42% and the Nifty Pharma sector index dropping 1.84%. Mankind Pharma&#8217;s decline tracked the weak broader pharmaceutical space closely, reflecting sector-wide headwinds rather than an isolated drop.<\/p>\n<p class=\"wt-copy\">Recent corporate updates show the company proceeding with the voluntary liquidation and integration of its material wholly-owned subsidiary, Bharat Serums and Vaccines Limited, alongside recent statutory auditor changes within that subsidiary. While these structural realisations provide ongoing operational context, no single direct corporate trigger was reported to account for today&#8217;s specific price movement.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\" class=\"wt-card\">\n<div style=\"gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\" class=\"wt-card-title\">\n<div style=\"font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p> <span style=\"background:#eef2f6;color:#526273;padding:3px 8px;border-radius:999px;font-weight:900;text-transform:uppercase;\">low confidence<\/span> <\/div>\n<div style=\"font-weight:850;color:#20384a;margin-bottom:7px;\">Sector-led pullback with elevated trading volume<\/div>\n<div style=\"\">The stock declined alongside a weak broader pharmaceutical sector while recording heavier-than-average volume. No immediate single catalyst was confirmed for today&#8217;s price action.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Nifty Pharma sector index fell 1.84%<\/li>\n<li>Trading volume reached 2.5 times the 20-day average<\/li>\n<\/ul><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid\" style=\"gap:16px;margin:14px 0 22px;width:100%;box-sizing:border-box;\">\n<div style=\"background:#fff5df;border:1px solid #ecd39e;border-left:5px solid #cc922c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\" class=\"wt-card wt-card\">\n<div style=\"margin:0 0 10px;color:#8c6318;\" class=\"wt-card-title\">Promoter Pledge \/ Encumbrance<\/div>\n<p style=\"margin:0;\" class=\"wt-copy\">Completion of Realignment of Security Cover in respect of Non-ConvertibleDebentures and Consequent Release of Pledged Shares of Bharat Serums andVaccines Limited<\/p>\n<p style=\"margin:10px 0 0;color:#7b673d;\" class=\"wt-copy\">Source: NSE corporate filing<\/p>\n<\/p><\/div>\n<div style=\"background:#f5f8fb;border:1px solid #d5e0ea;border-left:5px solid #6a849c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\" class=\"wt-card wt-card\">\n<div style=\"margin:0 0 10px;color:#405d76;\" class=\"wt-card-title\">Recent Ownership \/ Shareholding Disclosure<\/div>\n<div style=\"\">Promoters and promoter group confirmed no encumbrances were made on their holdings during the financial year ended March 31, 2026, and security covers regarding non-convertible debentures tied to Bharat Serums and Vaccines were successfully realigned with pledged shares released in August 2026.<\/div>\n<ul style=\"margin:10px 0 0;padding-left:18px;\">\n<li>Promoter group submitted disclosures under Regulation 31(4) of SEBI Takeover Regulations confirming zero encumbrances for FY ending March 31, 2026.<\/li>\n<li>Security cover realignment for non-convertible debentures resulted in the release of pledged shares of Bharat Serums and Vaccines Limited in August 2026.<\/li>\n<\/ul>\n<p style=\"margin:10px 0 0;color:#647789;\" class=\"wt-copy\">Source: NSE corporate disclosure. Only factual ownership\/shareholding details extracted from the filing are shown.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p class=\"wt-copy\"><strong>Price Position:<\/strong>The stock is around the middle of the day&#8217;s trading range. <\/p>\n<p class=\"wt-copy\"><strong>Move From Open:<\/strong>-1.44%. <\/p>\n<p class=\"wt-copy\"><strong>Intraday Range:<\/strong>3.81% of the previous close. <\/p>\n<p class=\"wt-copy\"><strong>5-Day Performance:<\/strong>+1.57%; <strong>20-Day Performance:<\/strong>+4.70%. <\/p>\n<\/p><\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\" class=\"wt-card\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Integration of Bharat Serums and Vaccines Limited via Voluntary Liquidation<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">26-Aug-2026<\/div>\n<div style=\"\">The board of directors approved the integration of Bharat Serums and Vaccines Limited, a wholly-owned material subsidiary, into Mankind Pharma through voluntary liquidation. Subsequent updates in September 2026 confirmed progress on this restructuring path and noted the resignation of statutory auditors at the subsidiary level. These corporate actions form part of the group&#8217;s ongoing subsidiary rationalisation and corporate structure streamlining.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Streamlining material subsidiaries helps simplify group holding structures and enhances operational synergy, though administrative changes like auditor resignations warrant monitoring for smooth execution. <\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-weight:800;color:#17324d;margin-bottom:4px;\">Exclusive In-Licensing Agreement for Insulin Products<\/div>\n<div style=\"color:#708090;margin-bottom:6px;\">20-Aug-2026<\/div>\n<div style=\"\">Mankind Pharma entered into an exclusive in-licensing agreement for Insulin Degludec and Insulin Degludec plus Aspart combination products for the Indian market. This strategic addition expands the company&#8217;s anti-diabetic portfolio into specialized, advanced chronic care segments. The partnership reinforces its ongoing push to widen chronic therapy offerings.<\/div>\n<div style=\"margin-top:8px;color:#4f5f6e;\"><strong>Why it matters:<\/strong>Expanding into high-margin chronic therapies such as advanced insulin variants strengthens the company&#8217;s competitive positioning in the domestic diabetes management market. <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\" class=\"wt-card\"><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Progress updates regarding the voluntary liquidation and integration of Bharat Serums and Vaccines Limited<\/li>\n<li>Delivery volume trends following the higher-than-average turnover observed today<\/li>\n<li>Performance of the Nifty Pharma sector benchmark for continued directional cues<\/li>\n<li>Execution progress on the newly in-licensed insulin product portfolio<\/li>\n<\/ul>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\" class=\"wt-copy\"><strong>Catalyst note:<\/strong>No single confirmed company-specific trigger caused today&#8217;s move; the decline aligns with broader sector weakness amid higher volume. <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p class=\"wt-copy\">The stock declined alongside a weak broader pharmaceutical sector while recording heavier-than-average volume. No immediate single catalyst was confirmed for today&#8217;s price action.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p class=\"wt-copy\">Today&#8217;s volume is 1,301,940. The latest 20-day average available is 521,289, equivalent to about 2.50x of the recent average.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p class=\"wt-copy\">Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the<a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>. <\/p>\n<div class=\"witty-related\"><\/div>\n<p><strong>Article by:<\/strong><a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><\/p>\n<div class=\"witty-disclaimer\"><strong>Disclaimer:<\/strong>Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors. This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security. Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions. <\/div>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-10-05\/\">Why Mankind Pharma Shares Fell 2.21% Today: Sector Weakness &amp; Context \u2014 5 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-10-01\/\">Why Mankind Pharma Shares Are Down 2.4% Today \u2014 1 October 2026<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/\">Mankind Pharma Share Price Rises Today: Why MANKIND Stock is Moving \u2014 29 September 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/mankind\/\">More Mankind Pharma news and dated analysis \u2192<\/a><\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-30\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-30\/\"}, \"headline\": \"Why Mankind Pharma Shares Fell 1.62% Today: Sector Trends | 30 September 2026\", \"description\": \"Mankind Pharma shares dropped 1.62% amid a weak pharmaceutical sector and higher volume. Read analysis on recent developments and what to watch next.\", \"datePublished\": \"2026-09-30T05:19:52Z\", \"dateModified\": \"2026-10-05T14:43:53.354897+00:00\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/mankind-company-news-2026-09-30.jpg\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma shares dropped 1.62% amid a weak pharmaceutical sector and higher volume. Read analysis on recent developments and what to watch next.<\/p>\n","protected":false},"author":1,"featured_media":3127,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Why Mankind Pharma Shares Fell 1.62% Today: Sector Trends | 30 September 2026","_witty_meta_description":"Mankind Pharma shares dropped 1.62% amid a weak pharmaceutical sector and higher volume. Read analysis on recent developments and what to watch next.","_witty_primary_phrase":"Mankind Pharma share price 2026-09-30","_witty_reason_label":"Sector-led pullback with elevated trading volume","_witty_reason_confidence":"low","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[32],"class_list":["post-953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-mankind"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=953"}],"version-history":[{"count":5,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/953\/revisions"}],"predecessor-version":[{"id":3130,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/953\/revisions\/3130"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/3127"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}